Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Glazer, WM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 42 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Morgenstern, H; Glazer, WM; Woods, SW
      Risperidone and tardive dyskinesia

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    2. Ereshefsky, L; Glazer, WM
      Conclusion - Comparison of the bioequivalence of generic versus branded clozapine

      JOURNAL OF CLINICAL PSYCHIATRY
    3. Glazer, WM; Woods, SW
      Should sisyphus have taken melatonin?

      ARCHIVES OF GENERAL PSYCHIATRY
    4. Glazer, WM
      Variations in practice

      PSYCHIATRIC SERVICES
    5. Glazer, WM
      Review of incidence studies of tardive dyskinesia associated with typical antipsychotics

      JOURNAL OF CLINICAL PSYCHIATRY
    6. Glazer, WM
      Expected incidence of tardive dyskinesia associated with atypical antipsychotics

      JOURNAL OF CLINICAL PSYCHIATRY
    7. Glazer, WM
      Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality

      JOURNAL OF CLINICAL PSYCHIATRY
    8. Voris, JC; Glazer, WM
      Use of risperidone and olanzapine in outpatient clinics at six veterans affairs hospitals

      PSYCHIATRIC SERVICES
    9. Dickson, RA; Glazer, WM
      Neuroleptic-induced hyperprolactinemia

      SCHIZOPHRENIA RESEARCH
    10. Dickson, RA; Glazer, WM
      Hyperprolactinemia and male sexual dysfunction

      JOURNAL OF CLINICAL PSYCHIATRY
    11. Glazer, WM
      Capitation - Reply

      JOURNAL OF CLINICAL PSYCHIATRY
    12. Glazer, WM
      Does loxapine have "atypical" properties? Clinical evidence

      JOURNAL OF CLINICAL PSYCHIATRY
    13. Beasley, CM; Dellva, MA; Tamura, RN; Morgenstern, H; Glazer, WM; Ferguson, K; Tollefson, GD
      Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol

      BRITISH JOURNAL OF PSYCHIATRY
    14. GLAZER WM
      ATYPICAL ANTIPSYCHOTICS AND FORMULARY DECISIONS

      American journal of managed care
    15. GLAZER WM
      DEFINING BEST PRACTICES - A PRESCRIPTION FOR GREATER AUTONOMY

      Psychiatric services
    16. TAMURA RN; BEASLEY CM; DELLVA MA; GLAZER WM; MORGENSTERN H; TOLLEFSON GD
      WHAT IS THE DIFFERENTIAL RISK OF TARDIVE-DYSKINESIA WITH THE NOVEL ANTIPSYCHOTIC OLANZAPINE

      Schizophrenia research
    17. SERNYAK MJ; GLAZER WM; HENINGER GR; CHARNEY DS; WOODS SW; PETRAKIS IL; KRYSTAL JH; PRICE LH
      NALTREXONE AUGMENTATION OF NEUROLEPTICS IN SCHIZOPHRENIA

      Journal of clinical psychopharmacology
    18. GLAZER WM; DICKSON RA
      CLOZAPINE REDUCES VIOLENCE AND PERSISTENT AGGRESSION IN SCHIZOPHRENIA

      The Journal of clinical psychiatry
    19. GLAZER WM; ROSENBAUM JF
      MANAGED CARE VERSUS MANAGED MONEY - INTRODUCTION

      The Journal of clinical psychiatry
    20. GLAZER WM; ROSENBAUM JF
      MANAGED CARE VERSUS MANAGED MONEY

      The Journal of clinical psychiatry
    21. GLAZER WM; ROSENBAUM JF
      ROLE OF MEDICATION IN MANAGED CARE FOR DEPRESSION

      The Journal of clinical psychiatry
    22. GLAZER WM; ROSENBAUM JF
      ROLE OF PSYCHIATRISTS IN MANAGED CARE SYSTEMS

      The Journal of clinical psychiatry
    23. Glazer, WM
      Formulary decisions and health economics

      JOURNAL OF CLINICAL PSYCHIATRY
    24. GLAZER WM
      DIAGNOSIS AND TREATMENT OF CHRONIC DEPRESSION - KOCSIS,JH, KLEIN,DN

      Psychiatric services
    25. GLAZER WM
      OLANZAPINE AND THE NEW-GENERATION OF ANTIPSYCHOTIC AGENTS - PATTERNS OF USE

      The Journal of clinical psychiatry
    26. GLAZER WM; JOHNSTONE BM
      PHARMACOECONOMIC EVALUATION OF ANTIPSYCHOTIC THERAPY FOR SCHIZOPHRENIA

      The Journal of clinical psychiatry
    27. GLAZER WM
      THE IMPACT OF MANAGED CARE SYSTEMS ON RELAPSE PREVENTION AND QUALITY-OF-LIFE FOR PATIENTS WITH SCHIZOPHRENIA

      European neuropsychopharmacology
    28. GLAZER WM; ERESHEFSKY L
      A PHARMACOECONOMIC MODEL OF OUTPATIENT ANTIPSYCHOTIC THERAPY IN REVOLVING-DOOR SCHIZOPHRENIC-PATIENTS

      The Journal of clinical psychiatry
    29. GLAZER WM; GRAY GV
      PSYCHOMETRIC PROPERTIES OF A DECISION-SUPPORT TOOL FOR THE ERA OF MANAGED CARE

      Journal of mental health administration
    30. SLAY JD; GLAZER WM
      CARVING IN, AND KEEPING IN, MENTAL-HEALTH-CARE IN THE MANAGED CARE SETTING

      Psychiatric services
    31. GLAZER WM
      THE PREFERRED PROVIDERS HANDBOOK - BUILDING A SUCCESSFUL PRIVATE THERAPY PRACTICE IN THE MARKETPLACE - POYNTER,WL

      The American journal of psychiatry
    32. GLAZER WM
      MANAGING MANAGED CARE - A MENTAL-HEALTH PRACTITIONERS SURVIVAL GUIDE - GOODMAN,M, BROWN,J, DEITZ,P

      The American journal of psychiatry
    33. GLAZER WM; KANE JM
      THE UNDERUTILIZATION OF DEPOT NEUROLEPTIC THERAPY - REPLY

      The Journal of clinical psychiatry
    34. ZIEDONIS DM; KOSTEN TR; GLAZER WM; FRANCES RJ
      NICOTINE DEPENDENCE AND SCHIZOPHRENIA

      Hospital & community psychiatry
    35. GLAZER WM
      WHAT ARE BEST PRACTICES - UNDERSTANDING THE CONCEPT

      Hospital & community psychiatry
    36. GLAZER WM; MORGENSTERN H; DOUCETTE J
      RACE AND TARDIVE-DYSKINESIA AMONG OUTPATIENTS AT A CMHC

      Hospital & community psychiatry
    37. GLAZER WM; MORGENSTERN H
      THE IMPACT OF UTILIZATION MANAGEMENT ON HOSPITAL LENGTH OF STAY AND ILLNESS

      Administration and policy in mental health
    38. GLAZER WM; MORGENSTERN H; DOUCETTE JT
      PREDICTING THE LONG-TERM RISK OF TARDIVE-DYSKINESIA IN OUTPATIENTS MAINTAINED ON NEUROLEPTIC MEDICATIONS

      The Journal of clinical psychiatry
    39. GLAZER WM
      PSYCHOTIC RELAPSE - A MULTISYSTEMS PERSPECTIVE - INTRODUCTION

      The Journal of clinical psychiatry
    40. ENGLAND MJR; GLAZER WM
      PSYCHOTIC RELAPSE - A MULTISYSTEMS PERSPECTIVE - DISCUSSANT SECTION

      The Journal of clinical psychiatry
    41. SATEL SL; GLAZER WM
      SUPPORTING ADDICTION WITH PUBLIC FUNDS

      Hospital & community psychiatry
    42. MORGENSTERN H; GLAZER WM
      IDENTIFYING RISK-FACTORS FOR TARDIVE-DYSKINESIA AMONG LONG-TERM OUTPATIENTS MAINTAINED WITH NEUROLEPTIC MEDICATIONS - RESULTS OF THE YALE TARDIVE-DYSKINESIA STUDY

      Archives of general psychiatry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/01/21 alle ore 08:45:53